Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Hengrui Acquires Rights to Novaliq Dry Eye Treatments in $165 Million Deal

publication date: Nov 11, 2019

Jiangsu Hengrui Medicine entered a $165 million agreement to in-license China rights for two dry eye treatments from Germany's Novaliq. Hengrui, which will pay $9 million upfront and up to $156 million in milestones, will develop, manufacture and commercialize the innovative, water-free drugs NOV03 and CyclASol® for greater China. Both drugs are in late stage US clinical trials. Novaliq says they have shown superior efficacy, with an early onset of action, excellent tolerability and better benefit-risk profiles than existing dry eye treatments. More details....

Stock Symbol: (SHA: 600276)

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here